Navigation Links
Call for Applications: The Amgen Award for Science Teaching Excellence

34 Outstanding Teachers Will Be Recognized in Communities Where Amgen


THOUSAND OAKS, Calif., Nov. 3 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced that it now invites applications for its 18th annual Amgen Award for Science Teaching Excellence (AASTE). This award is designed to recognize and honor extraordinary science teachers at the K-12 level who significantly impact their students through exemplary science teaching and who achieve demonstrated results in student learning in communities where Amgen operates.

With a longstanding commitment to science education, Amgen established the teacher awards program to promote and encourage science excellence in public and private schools. Since the program's inception in 1992, Amgen has awarded more than $2 million to educators who have made exceptional science-teaching contributions and who have significantly impacted the lives of their students.

Amgen is expanding its program this year, and will honor a total of 34 teachers in California, Colorado, Kentucky, Massachusetts, Puerto Rico, Rhode Island, Washington and Canada (Alberta, British Columbia, Ontario and Quebec). In addition, a new streamlined web-based application will be available this year.

"At Amgen, we believe that extraordinary teachers can inspire a passion for science," said Phyllis Piano, vice president, Corporate Communications and Philanthropy at Amgen. "Since the beginning of the AASTE program more than 200 teachers have been honored for their dedication, and we look forward to celebrating the achievements of this year's recipients."

The 34 selected winners within the United States, Puerto Rico and Canada will receive the following benefits:

-- An unrestricted cash award of $5,000USD or $5,000CAD; and

-- A restricted $5,000USD or $5,000CAD cash grant to the recipient's school for the expansion or enhancement of a school science program, science resources, or the professional development of the school's science teachers.

Applicants are required to submit an innovative lesson plan that they have successfully incorporated into their classroom and that can be shared with other teachers. A panel of independent judges will select the winners based on the following criteria: creativity and effectiveness of teaching methods; innovative lesson plan; and the plan for the use of grant money to improve science education resources in their schools.

A select number of the lesson plans submitted by 2009 AASTE Award winners will be posted to Amgen's Website, with the intent that other teachers will benefit from these innovative materials. Select lesson plans from 2007 and 2008 AASTE Award winners are available for download at no cost; educators are encouraged to review and implement any of these plans into their own curriculum.

Those interested in applying should visit for more information. The application can be completed online and French and Spanish applications are available in PDF format. Applications must be submitted by Feb. 2, 2009 to be valid. Winners will be notified in between April and June 2009.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit

CONTACT: Amgen, Thousand Oaks

Kristen Davis, (805) 447-3008 (media) (Logo:

Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Amgens Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23
2. Amgen Announces Webcast of 2008 Third Quarter Financial Results
3. Co-Inventor of Amgens Aranesp(R) Technology Directs Worldwide Patent Strategy for Diffusion Pharmaceuticals First-in-Class Oxygen Enhancing Therapeutics
4. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
5. Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer
6. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
7. More Than 230 Cyclists to Ride in Amgen California Coast Classic Bike Tour to Raise $1.3 Million for Arthritis Foundation
8. Amgen and Genentech Brace Themselves for Heavy Pressure From Biogenerics Manufacturers
9. NIH Awards Approximately $3M Grant for Research Involving WaferGens SmartChip(TM) Real-Time PCR System at the University of Pittsburgh
10. PAREXEL Partners with Glenmark to Win the Good Clinical Practice Journal Award for Most Innovative Patient Recruitment Strategy
11. Abbotts XIENCE V(TM) Drug Eluting Stent Wins Prestigious Chicago Innovation Award
Post Your Comments:
(Date:12/1/2015)... ... 01, 2015 , ... The American Society of Gynecologic Laparoscopists, ... Mathews will join fellow surgeons in the shared pursuit of ÔÇťadvancing minimally ... urogynecologist, founder of Plano Urogynecology Associates and Fellow of the American College ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... Manufacturing Practice (GMP) 10000 in the Santiago Marriott. The Global Stem Cells Group ... by a world-class team of qualified medical researchers and practitioners, experienced in administering ...
(Date:11/30/2015)... , Nov. 30, 2015  Culprits beware, a ... chemistry professor Jan Halámek, is taking crime scene ...   -->   ... --> --> ... have discovered a straightforward concept for identifying whether ...
(Date:11/30/2015)... , Nov. 30, 2015  Champions Oncology, Inc. ... and services to personalize the development and use of ... Chief Executive Officer, will be presenting at the LD ... 4:30pm Pacific Standard Time (PST).  The conference, held at ... Los Angeles, CA , will feature 200 small/micro-cap ...
Breaking Biology Technology:
(Date:11/18/2015)... ALBANY, New York , November 18, 2015 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2021. According to ... bn in 2014 and is anticipated to reach US$29.1 ... 2015 to 2021. North America ...
(Date:11/16/2015)... Nov 16, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced expansion of its TDDI product ... touch controller and display driver integration (TDDI) solutions ... These new TDDI products add to the previously-announced ... TD4302 (WQHD resolution), and TD4322 (FHD resolution) solutions. ...
(Date:11/10/2015)...  In this report, the biomarkers market ... type, application, disease indication, and geography. The ... consumables, services, software. The type segments included ... biomarkers, and validation biomarkers. The applications segments ... drug discovery and development, personalized medicine, disease ...
Breaking Biology News(10 mins):